Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV rt-PA (Activase) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset.
Latest Information Update: 09 Feb 2023
Price :
$35 *
At a glance
- Drugs Alteplase (Primary) ; Alteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms IMS-III
- 04 Jan 2023 Results (n=525) assessing to quantify the association between disabling neurological deficits and the EQ-5D dimension scores and the utility score in patients with ischemic stroke published in the Neurology
- 01 May 2020 Results of secondary analysis of IMS-III and NINDS tPA trials presented at the 72nd Annual Meeting of the American Academy of Neurology
- 21 Feb 2020 Results of pooled analysis of ALIAS I, II and IMS-III trials presented at the International Stroke Conference 2020